Metabolites (Nov 2023)

Cord Blood Metabolite Profiles and Their Association with Autistic Traits in Childhood

  • Christin S. Kaupper,
  • Sophia M. Blaauwendraad,
  • Charlotte A. M. Cecil,
  • Rosa H. Mulder,
  • Romy Gaillard,
  • Romy Goncalves,
  • Ingo Borggraefe,
  • Berthold Koletzko,
  • Vincent W. V. Jaddoe

DOI
https://doi.org/10.3390/metabo13111140
Journal volume & issue
Vol. 13, no. 11
p. 1140

Abstract

Read online

Autism Spectrum Disorder (ASD) is a diverse neurodevelopmental condition. Gene–environmental interactions in early stages of life might alter metabolic pathways, possibly contributing to ASD pathophysiology. Metabolomics may serve as a tool to identify underlying metabolic mechanisms contributing to ASD phenotype and could help to unravel its complex etiology. In a population-based, prospective cohort study among 783 mother–child pairs, cord blood serum concentrations of amino acids, non-esterified fatty acids, phospholipids, and carnitines were obtained using liquid chromatography coupled with tandem mass spectrometry. Autistic traits were measured at the children’s ages of 6 (n = 716) and 13 (n = 648) years using the parent-reported Social Responsiveness Scale. Lower cord blood concentrations of SM.C.39.2 and NEFA16:1/16:0 were associated with higher autistic traits among 6-year-old children, adjusted for sex and age at outcome. After more stringent adjustment for confounders, no significant associations of cord blood metabolites and autistic traits at ages 6 and 13 were detected. Differences in lipid metabolism (SM and NEFA) might be involved in ASD-related pathways and are worth further investigation.

Keywords